These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8249431)

  • 1. Study on the stability of 17D-204 yellow fever vaccine before and after stabilization.
    Sood DK; Aggarwal RK; Sharma SB; Sokhey J; Singh H
    Vaccine; 1993; 11(11):1124-8. PubMed ID: 8249431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stability of yellow fever vaccine.
    Monath TP
    Dev Biol Stand; 1996; 87():219-25. PubMed ID: 8854020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability of 17D yellow fever virus vaccine using different stabilizers.
    Adebayo AA; Sim-Brandenburg JW; Emmel H; Olaleye DO; Niedrig M
    Biologicals; 1998 Dec; 26(4):309-16. PubMed ID: 10403034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The thermal stability of yellow fever vaccines.
    Ishak R; Howard CR
    Mem Inst Oswaldo Cruz; 1990; 85(3):339-45. PubMed ID: 2134708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability-related studies on 17D yellow fever vaccine.
    Perraut R; Girault G; Moreau JP
    Microbes Infect; 2000 Jan; 2(1):33-8. PubMed ID: 10717538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the effect of various chemical stabilizers and lyophilization cycles on the thermostability of a Vero cell-adapted rinderpest vaccine.
    Mariner JC; House JA; Sollod AE; Stem C; van den Ende M; Mebus CA
    Vet Microbiol; 1990 Jan; 21(3):195-209. PubMed ID: 2305545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A rapid test for measuring the infectivity of Yellow Fever vaccine.
    Sood DK; Aggarwal RK; Kumar S; Sokhey J
    Vaccine; 1995 Apr; 13(5):427-8. PubMed ID: 7639009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thermostability and efficacy in the field of a new, stabilized yellow fever virus vaccine.
    Georges AJ; Tible F; Meunier DM; Gonzalez JP; Beraud AM; Sissoko-Dybdahl NR; Abdul-Wahid S; Fritzell B; Girard M; Georges-Courbot MC
    Vaccine; 1985 Sep; 3(3):313-5. PubMed ID: 4060841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The quality standardization of a national vaccine against yellow fever].
    Rasshchepkina MN; Levina VD; Vorob'eva MS; Kozlov VG
    Zh Mikrobiol Epidemiol Immunobiol; 1990 Jul; (7):47-50. PubMed ID: 2251891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A thermostable presentation of the live, attenuated peste des petits ruminants vaccine in use in Africa and Asia.
    Mariner JC; Gachanja J; Tindih SH; Toye P
    Vaccine; 2017 Jun; 35(30):3773-3779. PubMed ID: 28566253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative efficacy of various chemical stabilizers on the thermostability of a live-attenuated peste des petits ruminants (PPR) vaccine.
    Sarkar J; Sreenivasa BP; Singh RP; Dhar P; Bandyopadhyay SK
    Vaccine; 2003 Dec; 21(32):4728-35. PubMed ID: 14585683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on yellow fever vaccine. II--Stability of the reconstituted product.
    Lopes Ode S; Guimarães SS; de Carvalho R
    J Biol Stand; 1988 Apr; 16(2):71-6. PubMed ID: 3372544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The thermal stability of a stabilized 17D yellow fever virus vaccine.
    Burfoot C; Young PA; Finter NB
    J Biol Stand; 1977; 5(3):173-9. PubMed ID: 893463
    [No Abstract]   [Full Text] [Related]  

  • 14. A spray freeze dried micropellet based formulation proof-of-concept for a yellow fever vaccine candidate.
    Clénet D; Hourquet V; Woinet B; Ponceblanc H; Vangelisti M
    Eur J Pharm Biopharm; 2019 Sep; 142():334-343. PubMed ID: 31306751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Use of stabilized yellow fever vaccine 17D at the time of the yellow fever epidemic in Burkina Faso in 1983].
    Saluzzo JF; Some L; Baudon D; Girault G; Lhuillier M; Kambire PA; Roux JF; Digoutte JP
    Bull Soc Pathol Exot Filiales; 1985; 78(4):536-40. PubMed ID: 4075474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study on the stability of Japanese encephalitis vaccine--development of freeze-dry dosage form].
    Jou R; Kan S; Yang WJ; Huang C; Chang MK; Liau MY
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1996 Feb; 29(1):57-64. PubMed ID: 10592787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant, chimaeric live, attenuated vaccine (ChimeriVax) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective in non-human primates.
    Monath TP; Soike K; Levenbook I; Zhang ZX; Arroyo J; Delagrave S; Myers G; Barrett AD; Shope RE; Ratterree M; Chambers TJ; Guirakhoo F
    Vaccine; 1999 Apr; 17(15-16):1869-82. PubMed ID: 10217584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Stability of a new thermostable 17D yellow fever vaccine].
    Durand JP; Kollo B; Merlin M; Le Hesran JY; Josse R; Garrigue GP
    J Biol Stand; 1988 Jan; 16(1):1-7. PubMed ID: 3350820
    [No Abstract]   [Full Text] [Related]  

  • 19. [Thermostabilization of the lyophilized yellow fever vaccine 17-D. II. Pilot lots prepared under conditions of industrial production].
    Barme M; Vacher B; Ryhiner ML; Chabannier G
    J Biol Stand; 1987 Jan; 15(1):67-72. PubMed ID: 3558422
    [No Abstract]   [Full Text] [Related]  

  • 20. Sanger-based sequencing technology for yellow fever vaccine genetic quality control.
    Pestana CP; Lawson-Ferreira R; Lessa-Aquino C; Leal MDLF; Freire MDS; Homma A; Medeiros MA
    J Virol Methods; 2018 Oct; 260():82-87. PubMed ID: 30009851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.